CN101535286B - 色烯的对映选择性氢化方法 - Google Patents

色烯的对映选择性氢化方法 Download PDF

Info

Publication number
CN101535286B
CN101535286B CN200680036577.1A CN200680036577A CN101535286B CN 101535286 B CN101535286 B CN 101535286B CN 200680036577 A CN200680036577 A CN 200680036577A CN 101535286 B CN101535286 B CN 101535286B
Authority
CN
China
Prior art keywords
phenyl
equol
chromene
compound
chroman
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200680036577.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN101535286A (zh
Inventor
K·D·R·塞特查尔
V·D·索罗金
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cincinnati Childrens Hospital Medical Center
Girindus America Inc
Original Assignee
Cincinnati Childrens Hospital Medical Center
Girindus America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cincinnati Childrens Hospital Medical Center, Girindus America Inc filed Critical Cincinnati Childrens Hospital Medical Center
Priority to CN201310655782.8A priority Critical patent/CN103755675B/zh
Priority to CN201310533995.3A priority patent/CN103641808B/zh
Publication of CN101535286A publication Critical patent/CN101535286A/zh
Application granted granted Critical
Publication of CN101535286B publication Critical patent/CN101535286B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/38—2,3-Dihydro derivatives, e.g. isoflavanones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
CN200680036577.1A 2005-08-01 2006-08-01 色烯的对映选择性氢化方法 Expired - Fee Related CN101535286B (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201310655782.8A CN103755675B (zh) 2005-08-01 2006-08-01 色烯的对映选择性氢化方法
CN201310533995.3A CN103641808B (zh) 2005-08-01 2006-08-01 色烯的对映选择性氢化方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/194,280 US7528267B2 (en) 2005-08-01 2005-08-01 Method for enantioselective hydrogenation of chromenes
US11/194,280 2005-08-01
PCT/US2006/029589 WO2007016423A2 (en) 2005-08-01 2006-08-01 Method for enantioselective hydrogenation of chromenes

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CN201310533995.3A Division CN103641808B (zh) 2005-08-01 2006-08-01 色烯的对映选择性氢化方法
CN201310655782.8A Division CN103755675B (zh) 2005-08-01 2006-08-01 色烯的对映选择性氢化方法

Publications (2)

Publication Number Publication Date
CN101535286A CN101535286A (zh) 2009-09-16
CN101535286B true CN101535286B (zh) 2014-05-07

Family

ID=37695254

Family Applications (3)

Application Number Title Priority Date Filing Date
CN200680036577.1A Expired - Fee Related CN101535286B (zh) 2005-08-01 2006-08-01 色烯的对映选择性氢化方法
CN201310655782.8A Expired - Fee Related CN103755675B (zh) 2005-08-01 2006-08-01 色烯的对映选择性氢化方法
CN201310533995.3A Expired - Fee Related CN103641808B (zh) 2005-08-01 2006-08-01 色烯的对映选择性氢化方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN201310655782.8A Expired - Fee Related CN103755675B (zh) 2005-08-01 2006-08-01 色烯的对映选择性氢化方法
CN201310533995.3A Expired - Fee Related CN103641808B (zh) 2005-08-01 2006-08-01 色烯的对映选择性氢化方法

Country Status (8)

Country Link
US (4) US7528267B2 (cg-RX-API-DMAC7.html)
EP (1) EP1919887B1 (cg-RX-API-DMAC7.html)
JP (1) JP5507081B2 (cg-RX-API-DMAC7.html)
CN (3) CN101535286B (cg-RX-API-DMAC7.html)
AU (1) AU2006275587B2 (cg-RX-API-DMAC7.html)
CA (1) CA2617665C (cg-RX-API-DMAC7.html)
DK (1) DK1919887T3 (cg-RX-API-DMAC7.html)
WO (1) WO2007016423A2 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1569636B1 (en) 2002-10-29 2017-12-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
GB0610804D0 (en) * 2006-05-31 2006-07-12 Portela & Ca Sa New crystal forms
US7714348B2 (en) * 2006-10-06 2010-05-11 Ac-Led Lighting, L.L.C. AC/DC light emitting diodes with integrated protection mechanism
JP5355395B2 (ja) * 2007-06-13 2013-11-27 大塚製薬株式会社 エクオール含有抽出物及びその製造方法、エクオール抽出方法、並びにエクオールを含む食品
EP2231648A1 (en) * 2007-12-05 2010-09-29 BIAL - Portela & Ca., S.A. New salts and crystal forms
EP2133080A1 (de) 2008-06-13 2009-12-16 Haelan Schweiz GmbH Zusammensetzungen enthaltend Equol
RU2364442C1 (ru) * 2008-06-30 2009-08-20 Государственное образовательное учреждение высшего профессионального образования "Тверской государственный технический университет" Способ приготовления модифицированного платинового катализатора для энантиоселективного гидрирования сложных эфиров альфа-кетокарбоновых кислот
EP2154133A1 (de) * 2008-08-14 2010-02-17 System Biologie AG Synthese von Equol
US20110091435A1 (en) * 2008-10-24 2011-04-21 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of hair loss
US7875735B2 (en) * 2009-05-19 2011-01-25 Kaohsiung Medical University Processes for preparing isoflavonoids using 7-benzyloxy-3-(4-methoxyphenyl)-2H-1-benzopyran as a starting material
US7875736B2 (en) * 2009-05-19 2011-01-25 Kaohsiung Medical University Intermediate compounds and processes for the preparation of 7-benzyloxy-3-(4-methoxyphenyl)-2H-1-benzopyran
JP5780651B2 (ja) * 2009-09-18 2015-09-16 不二製油株式会社 エクオールの不斉合成法
CN102633763B (zh) * 2012-04-11 2014-02-26 黑龙江大学 一种(s)-雌马酚的制备方法
DK2953938T3 (en) 2014-02-07 2017-10-02 Novogen ltd Functionalized benzopyran compounds and their use
DK3191464T3 (da) * 2014-09-10 2020-02-03 System Biologie Ag Syntese af isoflavaner og intermediater deraf
EP3207034B1 (en) 2014-10-14 2023-06-07 Richard L. Jackson Anhydrous crystalline form of s-equol
AU2017301596A1 (en) 2016-07-26 2019-02-07 Ausio Pharmaceuticals, Llc Methods of diagnosing and treating Alzheimer's disease with S-equol
EP3843718A1 (en) 2018-06-15 2021-07-07 The Board Of Regents Of The University Of Texas System Methods of treating and preventing melanoma with s-equol
WO2019240871A1 (en) 2018-06-15 2019-12-19 The Board Of Regents Of The University Of Texas System Methods of treating and preventing breast cancer with s-equol
KR102819124B1 (ko) * 2018-10-02 2025-06-12 주식회사 글라세움 탄소 이중결합 함유 화합물의 비대칭 수소첨가 반응용 촉매
WO2020071818A1 (ko) * 2018-10-02 2020-04-09 주식회사 글라세움 탄소 이중결합 함유 화합물의 비대칭 수소첨가 반응용 촉매

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1340048A (zh) * 1999-02-15 2002-03-13 诺沃根研究有限公司 异黄酮衍生物的制备

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264509A (en) * 1977-06-08 1981-04-28 Z-L Limited Partnership Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
GB8626344D0 (en) * 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
KR20000057548A (ko) * 1996-12-13 2000-09-25 알프레드 엘. 미첼슨 광학적 전송물질 및 결합재
DE69833365T2 (de) * 1997-03-06 2006-09-28 Mitsui Chemicals, Inc. Verfahren zur herstellung optisch aktiver amine
WO2001034612A2 (en) * 1999-11-10 2001-05-17 The Penn State Research Foundation Chiral phosphines, transition metal complexes thereof and uses thereof in asymmetric reactions
SE9904850D0 (sv) * 1999-12-30 1999-12-30 Pharmacia & Upjohn Ab Novel process and intermediates
DE10044091A1 (de) * 2000-09-07 2002-04-04 Merck Patent Gmbh Chromanonderivate
ES2240297T3 (es) * 2000-09-21 2005-10-16 Solvias Ag Fosfinito-oxazolinas y complejos metalicos.
WO2003023056A2 (en) 2001-09-12 2003-03-20 F. Hoffmann-La Roche Ag Specific markers for multiple sclerosis
AU2003259220C1 (en) * 2002-07-24 2017-08-24 Australian Health & Nutrition Association Limited Compositions and products containing enantiomeric equol, and methods for their making
DE10237648A1 (de) 2002-08-13 2004-02-26 Behr Gmbh & Co. Wärmeübertrager
EP1569636B1 (en) 2002-10-29 2017-12-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
AU2002952453A0 (en) 2002-11-01 2002-11-21 Novogen Research Pty Ltd Aminated isoflavonoid derivatives and uses thereof
CA2510445A1 (en) * 2002-12-19 2004-07-08 Pharmacia Corporation Methods and compositions for the treatment of herpes virus infections using cyclooxygenase-2 selective inhibitors or cyclooxygenase-2 inhibitors in combination with antiviral agents
ITMI20031354A1 (it) 2003-07-02 2005-01-03 Istituto Di Chimica Biomolecolare D El Cnr Sezione Sintesis enantioselettiva di composti enantiomericamente arricchiti.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1340048A (zh) * 1999-02-15 2002-03-13 诺沃根研究有限公司 异黄酮衍生物的制备

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Andreas Pfaltz, et. al..Iridium-Catalyzed Enantioselective Hydrogenation of Olefins.《Adv. Synth. Catal.》.2003,第345卷33-43，特别是第41页图12的Ir-B2. *

Also Published As

Publication number Publication date
WO2007016423A2 (en) 2007-02-08
US7960573B2 (en) 2011-06-14
JP5507081B2 (ja) 2014-05-28
CN103641808A (zh) 2014-03-19
CA2617665A1 (en) 2007-02-08
WO2007016423A3 (en) 2009-04-30
CN103755675A (zh) 2014-04-30
US20100069653A1 (en) 2010-03-18
US7528267B2 (en) 2009-05-05
EP1919887B1 (en) 2015-02-18
AU2006275587A1 (en) 2007-02-08
US8263790B2 (en) 2012-09-11
US20120004427A1 (en) 2012-01-05
CN103755675B (zh) 2015-11-18
US20130116450A1 (en) 2013-05-09
DK1919887T3 (en) 2015-05-26
JP2009503079A (ja) 2009-01-29
EP1919887A4 (en) 2011-01-19
US8716497B2 (en) 2014-05-06
US20070027329A1 (en) 2007-02-01
EP1919887A2 (en) 2008-05-14
CN103641808B (zh) 2016-04-20
AU2006275587B2 (en) 2012-09-13
CN101535286A (zh) 2009-09-16
CA2617665C (en) 2014-12-02

Similar Documents

Publication Publication Date Title
CN101535286B (zh) 色烯的对映选择性氢化方法
CN100564370C (zh) 异黄酮衍生物的制备
KR920001776B1 (ko) 디하이드로벤조피란 유도체의 제조방법
JP7039643B2 (ja) カテキンの新規合成手法
JPS6026795B2 (ja) クロマン誘導体の製造方法
TW201309662A (zh) 多酚新合成方法
CN101952270B (zh) 制备奈必洛尔的方法
KR20170054461A (ko) 이소플라반 및 이의 중간체의 합성
EP1240155A1 (en) Metal salts of 3-methyl-chromane or thiochromane derivatives
CN105358541B (zh) 在酚或硫酚的存在下使用手性吡咯烷来形成手性4‑苯并二氢吡喃酮
CN105358540A (zh) 在脲或硫脲的存在下使用手性吡咯烷来形成手性4-苯并二氢吡喃酮
JPH11228563A (ja) ３−ヒドロキシ−２，３−ジヒドロベンゾフラン（又はベンゾチオフェン）誘導体及びそれを有効成分とする肝疾患治療薬
Malik Total synthesis of natural product pterocarpans useful as selective estrogen receptor modulators

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140507

Termination date: 20200801